Tachycardia clinical trials at UCSF

3 in progress, 2 open to eligible people

Tachycardia occurs when the heart rate is higher than normal. UCSF is researching a cryoablation system for its effectiveness in treating ventricular tachycardia. UCSF is also observing fetuses with atrial flutter and supraventricular tachycardia to gather important data.

Showing trials for

  • Cryoablation for Monomorphic Ventricular Tachycardia

    open to eligible people ages 18 years and up

    The objective of this clinical study is to evaluate the safety and effectiveness of the Adagio VT Cryoablation System in the ablation treatment of Sustained Monomorphic Ventricular Tachycardia (SMVT)

    San Francisco, California and other locations

  • Observational Cohort Study of Fetal Atrial Flutter & Supraventricular Tachycardia

    open to eligible females ages 16-50

    The FAST Trial Registry is a prospective observational cohort study of fetuses with a new diagnosis of atrial flutter (AF) or supraventricular tachycardia (SVT) that is severe enough to consider prenatal treatment (see eligibility criteria below). Aims of the Registry include to establish a large clinical database to determine and compare the efficacy and safety of different prenatal treatment strategies including observation without immediate treatment, transplacental antiarrhythmic fetal treatment and direct fetal treatment from the time of tachycardia diagnosis to death, neonatal hospital discharge or to a maximum of 30 days after birth.

    San Francisco, California and other locations

  • IVTCC 2.0: a Prospective Multicenter Ventricular Tachycardia Catheter Ablation Registry

    Sorry, accepting new patients by invitation only

    This is a prospective multi-center international registry. The objective of this registry is to collect prospective data on patients undergoing catheter ablation for Ventricular Tachycardia (VT) and Premature Ventricular Contractions (PVC). The registry will be used for clinical monitoring, research, and quality improvement purposes.

    San Francisco, California and other locations

Our lead scientists for Tachycardia research studies include .

Last updated: